HNL Lab Medicine

HNL Lab Medicine is a leading full-service medical laboratory headquartered in Allentown, Pennsylvania. The company's core mission is "to bring clarity to care; providing trusted answers that shape a healthier future." It provides comprehensive diagnostic testing and related services across Pennsylvania and New Jersey.

HNL Lab Medicine offers a broad spectrum of services, including anatomic pathology, digital pathology, forensic pathology, genetic testing, toxicology and drug screening, hematopathology, and molecular diagnostics. These services cater to a diverse clientele, including physician offices, hospitals, long-term care facilities, employers, and individual patients through its extensive network of over 50 patient service centers and direct-to-consumer lab testing options.

Led by President and CEO Martin K. Till, HNL Lab Medicine maintains a strong market position as a multi-regional diagnostic provider, processing over 60 million pathology results annually for millions of patients and thousands of healthcare providers. Recent initiatives include expanding its service footprint with new patient service centers, strengthening its IT leadership, and forming a preferred partnership with Roche Diagnostics in April 2026 to enhance diagnostic solutions. The company also actively addresses industry needs through programs like its Career Connections, aimed at developing future laboratory professionals.